FDA approves Pomalyst for advanced multiple myeloma
[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after
FDA approves Gleevec for children with acute lymphoblastic leukemia
[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with
Must Read – Pharmacy Poem: Effects of Drugs
An exclusive pharmacy poem was added to make you laugh. Have knowledge, Have fun!
FDA alerts health care providers of recall of anemia drug Omontys
The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all
Named Organic Reactions
Thomas Laue, Andreas Plagens – Named Organic Reactions (2nd edition) Named reactions still are an important element of organic chemistry,
Researchers identify first drug targets in childhood genetic tumor disorder.
[column]Two mutations central to the development of infantile myofibromatosis (IM) – a disorder characterized by multiple tumors involving